CURRENT AFFAIRS

Detailed explanation-1: -Isomorphic Labs is a drug discovery company launched in the United Kingdom in November 2021. The company was established under Alphabet Inc ., the parent company of Google. It is led by Demis Hassabis. Isomorphic Labs was incorporated in February 2021 and announced on November 5, 2021.

Detailed explanation-2: -Founded in 2021, CardiaTec Biosciences, a Cambridge, UK-based AI drug development firm focused on cardiovascular illnesses, has raised $1.4 million in pre-seed funding. They want to use the cash to create a target discovery platform capable of analyzing vast amounts of multi-omic data.

Detailed explanation-3: -Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.

Detailed explanation-4: -Dubbed Isomorphic Labs, the commercial venture plans to build off Alphabet’s DeepMind AI research incubator, and it shares that venture’s founder and CEO, Demis Hassabis.

Detailed explanation-5: -Google’s parent company Alphabet is diving into the drug discovery game with an artificial intelligence company built on the protein-folding simulation successes achieved at DeepMind.